Get your Pfizer COVID-19 vaccine. Walk-ins welcome! Monday through Thursday: 8 a.m. - 5 p.m. and Friday: 8 a.m. - noon >

Showing 1 - 1 of 1 Hemoglobinopathies
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Subjects With Pyruvate Kinase Deficiency

Status: Open Not Enrolling

Investigator: Lawrence Rice

Study Coordinator: Juan Morales Viera

Phone: 786.803.2333

Study AG348-C-006 will evaluate the efficacy and safety of orally administered AG-348 as compared with placebo in participants with pyruvate kinase deficiency (PKD), who are not regularly receiving blood transfusions. Participants will be random ... Read more >